273 related articles for article (PubMed ID: 21292324)
1. Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
Verweij MC; Ressing ME; Knetsch W; Quinten E; Halenius A; van Bel N; Hengel H; Drijfhout JW; van Hall T; Wiertz EJ
Mol Immunol; 2011 Mar; 48(6-7):835-45. PubMed ID: 21292324
[TBL] [Abstract][Full Text] [Related]
2. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.
Koppers-Lalic D; Reits EA; Ressing ME; Lipinska AD; Abele R; Koch J; Marcondes Rezende M; Admiraal P; van Leeuwen D; Bienkowska-Szewczyk K; Mettenleiter TC; Rijsewijk FA; Tampé R; Neefjes J; Wiertz EJ
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5144-9. PubMed ID: 15793001
[TBL] [Abstract][Full Text] [Related]
3. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
[TBL] [Abstract][Full Text] [Related]
4. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
[TBL] [Abstract][Full Text] [Related]
5. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins.
Praest P; Luteijn RD; Brak-Boer IGJ; Lanfermeijer J; Hoelen H; Ijgosse L; Costa AI; Gorham RD; Lebbink RJ; Wiertz EJHJ
Mol Immunol; 2018 Sep; 101():55-64. PubMed ID: 29879547
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.
Dugan GE; Hewitt EW
J Virol; 2008 Apr; 82(7):3271-82. PubMed ID: 18199642
[TBL] [Abstract][Full Text] [Related]
8. TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.
Oosten LE; Koppers-Lalic D; Blokland E; Mulder A; Ressing ME; Mutis T; van Halteren AG; Wiertz EJ; Goulmy E
Int Immunol; 2007 Sep; 19(9):1115-22. PubMed ID: 17855435
[TBL] [Abstract][Full Text] [Related]
9. Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution.
Verweij MC; Horst D; Griffin BD; Luteijn RD; Davison AJ; Ressing ME; Wiertz EJ
PLoS Pathog; 2015 Apr; 11(4):e1004743. PubMed ID: 25880312
[TBL] [Abstract][Full Text] [Related]
10. A viral inhibitor of peptide transporters for antigen presentation.
Früh K; Ahn K; Djaballah H; Sempé P; van Endert PM; Tampé R; Peterson PA; Yang Y
Nature; 1995 Jun; 375(6530):415-8. PubMed ID: 7760936
[TBL] [Abstract][Full Text] [Related]
11. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.
Horst D; van Leeuwen D; Croft NP; Garstka MA; Hislop AD; Kremmer E; Rickinson AB; Wiertz EJ; Ressing ME
J Immunol; 2009 Feb; 182(4):2313-24. PubMed ID: 19201886
[TBL] [Abstract][Full Text] [Related]
12. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.
Momburg F; Hengel H
Curr Top Microbiol Immunol; 2002; 269():57-74. PubMed ID: 12224516
[TBL] [Abstract][Full Text] [Related]
13. Interaction of murine MHC class I molecules with tapasin and TAP enhances peptide loading and involves the heavy chain alpha3 domain.
Suh WK; Derby MA; Cohen-Doyle MF; Schoenhals GJ; Früh K; Berzofsky JA; Williams DB
J Immunol; 1999 Feb; 162(3):1530-40. PubMed ID: 9973410
[TBL] [Abstract][Full Text] [Related]
14. Viral interference with antigen presentation: trapping TAP.
Ressing ME; Luteijn RD; Horst D; Wiertz EJ
Mol Immunol; 2013 Sep; 55(2):139-42. PubMed ID: 23141382
[TBL] [Abstract][Full Text] [Related]
15. The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.
Verweij MC; Lipinska AD; Koppers-Lalic D; van Leeuwen WF; Cohen JI; Kinchington PR; Messaoudi I; Bienkowska-Szewczyk K; Ressing ME; Rijsewijk FA; Wiertz EJ
J Virol; 2011 Mar; 85(5):2351-63. PubMed ID: 21159875
[TBL] [Abstract][Full Text] [Related]
16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus turns off the TAP to evade host immunity.
Hill A; Jugovic P; York I; Russ G; Bennink J; Yewdell J; Ploegh H; Johnson D
Nature; 1995 Jun; 375(6530):411-5. PubMed ID: 7760935
[TBL] [Abstract][Full Text] [Related]
18. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues.
Galocha B; Hill A; Barnett BC; Dolan A; Raimondi A; Cook RF; Brunner J; McGeoch DJ; Ploegh HL
J Exp Med; 1997 May; 185(9):1565-72. PubMed ID: 9151894
[TBL] [Abstract][Full Text] [Related]
19. A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter.
Oldham ML; Hite RK; Steffen AM; Damko E; Li Z; Walz T; Chen J
Nature; 2016 Jan; 529(7587):537-40. PubMed ID: 26789246
[TBL] [Abstract][Full Text] [Related]
20. EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAP.
Horst D; Favaloro V; Vilardi F; van Leeuwen HC; Garstka MA; Hislop AD; Rabu C; Kremmer E; Rickinson AB; High S; Dobberstein B; Ressing ME; Wiertz EJ
J Immunol; 2011 Mar; 186(6):3594-605. PubMed ID: 21296983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
